视网膜剥离诊断市场－全球产业规模、份额、趋势、机会、预测：按疾病类型、诊断方法、地区和竞争格局划分，2021-2031年

全球视网膜剥离诊断市场预计将从 2025 年的 21.8 亿美元成长到 2031 年的 30.1 亿美元，复合年增长率为 5.52%。

此市场领域涵盖用于区分神经感觉视网膜和视网膜色素上皮的医学影像系统和诊断设备，特别是光学同调断层扫描（OCT）和眼科超音波设备。推动该市场成长的主要因素是全球高度近视盛行率的上升和人口老化，这两者都会显着增加后玻璃体剥离和视网膜裂孔的风险。根据美国眼科学会（ARVO）发布的2025年数​​据，与近视相关的视网膜剥离影响约每10万人中有7.8人，凸显了便利、准确的诊断通讯协定的迫切需求。

然而，在资源匮乏的环境中部署先进的诊断成像基础设施成本高昂，这成为市场扩张的一大障碍。现代诊断平台所需的大量资本投入限制了其在发展中地区的普及，也阻碍了其在患者数量最多的地区的市场渗透。这种经济限制迫使许多医疗机构依赖人工检查方法，阻碍了自动化诊断解决方案的广泛应用，并减缓了新兴经济体的收入成长。

市场驱动因素

将人工智慧 (AI) 应用于视网膜诊断筛检正发挥变革性作用，提高了光学同调断层扫描(OCT) 和眼底成像诊断的准确性，并能够更早地识别视网膜剥离风险。 AI 演算法对于简化临床工作流程至关重要，尤其是在检测人工检查可能遗漏的细微视网膜裂孔和牵引性隆起方面。随着医疗机构诊断能力的提升，这项技术的应用正在推动市场实现实际成长。例如，根据 OptoMed 于 2025 年 2 月发布的“2024 年 1 月至 12 月初步财务快报”，该公司第四季度设备收入增长了 149.3%，主要得益于市场对整合 AI 的便携式筛检解决方案的需求。

同时，糖尿病视网膜病变和全身性疾病负担的加重，持续推动市场扩张，因为代谢性疾病常诱发牵拉性视网膜剥离。大量需要长期照护的高风险患者凸显了对玻璃体视网膜介面进行持续监测的迫切需求。根据 News-Medical.Net 2025 年 3 月报道，最新数据显示，超过 30% 的糖尿病患者患有某种形式的糖尿病视网膜疾病，这造成了对定期诊断监测的巨大需求。这种疾病负担正在推动整个眼科医疗保健领域的发展，爱尔康公司 2025 年 3 月发布的 2024 财年年度报告显示，其手术业务部门的净销售额达到 55 亿美元，这凸显了依赖精准上游诊断的医疗保健生态系统的庞大规模。

市场挑战

全球视网膜剥离诊断市场面临的一大挑战是部署现代影像基础设施的高昂成本。光同调断层扫瞄（OCT）和专用眼科超音波设备等诊断系统需要大量资金投入，这为资源有限的医疗机构设置了很高的进入门槛。在许多发展中地区，医院预算捉襟见肘，迫使管理者优先考虑基本营运支出，而非购置自动化诊断平台。这种资金差距实际上将很大一部分潜在的全球基本客群排除在外，使得製造商难以进入临床需求量最大的庞大市场。

因此，投资这些技术的难度限制了市场的地理扩张，并导致人们继续依赖准确度较低的人工检测方法。这种现代化进程的滞后减缓了老旧设备的更新换代，并限制了供应商的收入来源。根据国际防盲协会（IAPB）发布的《2025年报告》，需要71亿美元才能在低收入和中等收入地区充分扩大包括筛检在内的重点眼科干预措施。这一巨大的投资缺口凸显了新兴经济体面临的严峻经济压力，这些压力直接阻碍了必要诊断技术的应用。

市场趋势

存转眼科网路的扩展正在从根本上改变我们的诊断方式，它将影像检查与即时诊断分开。这种运作模式允许卫星诊所的技术人员使用自动眼底摄影机和光同调断层扫瞄）设备获取视网膜扫描影像，然后将其传输给中心专家进行非同步审查。这种去中心化的生态系统对于扩大诊断范围，涵盖医疗资源匮乏、玻璃体视网膜专科医生稀缺的地区至关重要，并且能够有效地对有视网膜剥离风险的患者进行分诊，防止视力丧失不可逆转。随着对这种互联诊断基础设施的依赖性不断增强，对相容成像设备的需求也显着增长。根据拓普康公司2025年5月发布的报告，该公司眼科业务部门的营收年增9.1%，达到843亿日圆，主要得益于其筛检业务和直销通路的快速扩张。

同时，实时术中光学同调断层扫描（iOCT）的引入实现了视网膜结构的即时可视化，加速了复杂视网膜剥离手术的进展。与传统的术前影像不同，iOCT可在手术过程中为外科医生提供关于神经感觉视网膜膜脱离和復位的即时高解析度回馈，显着提升临床决策能力并降低再次手术的可能性。这一趋势表明，手术流程正朝着诊断和治疗融合的一体化方向发展。这些技术的市场地位也反映在其财务表现上。根据卡尔蔡司医疗技术公司于2024年12月发布的2023/24年度报告，其眼科策略业务部门的收入达到15.892亿欧元，其中近期收购视网膜手术专家DORC为其互联手术和诊断技术组合贡献了9,990万欧元。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球视网膜剥离诊断市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 疾病类型（裂孔性视网膜剥离、渗出性视网膜剥离、浆液性或续发性视网膜剥离、牵拉性视网膜剥离）
  • 诊断方法（眼底照相、眼底镜检查、数位眼底摄影机、萤光造影等）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美视网膜剥离诊断市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲视网膜剥离诊断市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区视网膜剥离诊断市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲视网膜剥离诊断市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲视网膜剥离诊断市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球视网膜剥离诊断市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Canon Medical Systems Corporation
• Carl Zeiss Meditec Inc.
• Revenio Group Corporation
• Eyenuk Inc.
• Essilor International SA
• HealPros LLC
• Millennium Surgical Corp.
• ONL Therapeutics
• Peek Vision Ltd
• Parata Systems LLC

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Retinal Detachment Diagnostic Market is projected to expand from a valuation of USD 2.18 Billion in 2025 to USD 3.01 Billion by 2031, reflecting a compound annual growth rate of 5.52%. This market sector encompasses medical imaging systems and examination devices, specifically optical coherence tomography and ocular ultrasound, which are used to identify the separation of the neurosensory retina from the retinal pigment epithelium. Growth is primarily fueled by the rising global prevalence of high myopia and an aging demographic, both of which significantly increase the risk of posterior vitreous detachment and retinal tears. Data published by the Association for Research in Vision and Ophthalmology in 2025 indicates that retinal detachment following myopia affects approximately 7.8 individuals per 100,000, underscoring the critical need for accessible and precise diagnostic protocols.

However, market expansion faces a substantial hurdle due to the high acquisition costs associated with advanced imaging infrastructure in resource-limited settings. The significant financial investment required for modern diagnostic platforms restricts their availability in developing regions, thereby limiting market penetration in areas where patient volume is often highest. This economic constraint compels many healthcare facilities to rely on manual examination methods, ultimately hindering the widespread adoption of automated diagnostic solutions and slowing revenue growth in emerging economies.

Market Driver

The integration of Artificial Intelligence in Retinal Diagnostic Screening serves as a transformative driver, improving the precision of optical coherence tomography and fundus imaging to identify detachment risks at an earlier stage. AI algorithms are becoming essential for streamlining clinical workflows, particularly in detecting subtle retinal tears or tractional elevations that manual examinations might miss. This technological adoption is generating tangible market growth as healthcare facilities upgrade their diagnostic capabilities; for instance, Optomed's 'Financial Statements Bulletin, January - December 2024', released in February 2025, reported a 149.3 percent revenue surge in their Devices segment during the fourth quarter, primarily driven by demand for AI-integrated handheld screening solutions.

Simultaneously, the escalating burden of diabetic retinopathy and systemic diseases acts as a relentless catalyst for market expansion, as metabolic disorders frequently precipitate tractional retinal detachment. The need for constant surveillance of the vitreoretinal interface is intensifying due to the sheer volume of at-risk patients requiring longitudinal care. According to News-Medical.Net in March 2025, recent data indicates that more than 30 percent of all patients with diabetes now possess some form of diabetic retinal disease, creating a massive requirement for regular diagnostic monitoring. This disease burden fuels the broader ophthalmic sector, as evidenced by Alcon's March 2025 '2024 Annual Report', which noted that their Surgical business generated $5.5 billion in net sales, underscoring the immense scale of the healthcare ecosystem relying on accurate upstream diagnostics.

Market Challenge

The primary challenge hampering the Global Retinal Detachment Diagnostic Market is the prohibitive acquisition cost associated with modern imaging infrastructure. Examination systems such as optical coherence tomography and specialized ocular ultrasound units require substantial capital expenditure, creating a formidable barrier to entry for healthcare facilities in resource-limited settings. In many developing regions, hospital budgets are severely constrained, forcing administrators to prioritize basic operational expenses over the procurement of automated diagnostic platforms. This financial disparity effectively excludes a large segment of the potential global customer base, preventing manufacturers from tapping into high-volume markets where the clinical need is often greatest.

Consequently, the inability to invest in these technologies restricts the market's geographic expansion and sustains a reliance on less accurate, manual examination methods. This lack of modernization slows the replacement cycle of legacy equipment and limits the revenue streams available to device vendors. According to the International Agency for the Prevention of Blindness in 2025, a funding requirement of $7.1 billion was identified to adequately scale priority eye care interventions, including screenings, across low- and middle-income regions. This significant investment gap highlights the acute economic pressures that directly block the widespread adoption of necessary diagnostic technologies in emerging economies.

Market Trends

The expansion of Store-and-Forward Tele-ophthalmology Networks is fundamentally reshaping diagnostics by decoupling image capture from immediate interpretation. This operational model enables technicians in satellite clinics to acquire retinal scans using automated fundus cameras or optical coherence tomography, which are then transmitted to centralized specialists for asynchronous review. This distributed ecosystem is crucial for extending diagnostic reach into underserved regions where vitreoretinal specialists are scarce, effectively triaging patients with potential detachments before vision loss becomes irreversible. The growing reliance on these connected diagnostic infrastructures is driving substantial demand for compatible imaging hardware; according to Topcon Corporation's May 2025 report, revenue for their Eye Care business unit increased by 9.1 percent year-on-year to 84.3 billion yen, fueled notably by the rapid expansion of their screening business and direct sales channels.

Concurrently, the implementation of Real-Time Intraoperative Optical Coherence Tomography (iOCT) is advancing complex detachment surgeries by providing live visualization of the retinal architecture. Unlike traditional pre-operative imaging, iOCT offers surgeons immediate, high-resolution feedback on membrane peeling and the re-apposition of the neurosensory retina during the procedure, significantly enhancing clinical decision-making and reducing the likelihood of re-operation. This trend represents a shift towards integrated surgical workflows where diagnostics and treatment converge. The market prioritization of these combined technologies is evident in financial performance; according to Carl Zeiss Meditec's 'Annual Report 2023/24' from December 2024, the Ophthalmology Strategic Business Unit generated revenue of €1,589.2 million, with the recent acquisition of the retinal surgical specialist DORC contributing €99.9 million to their portfolio of connected surgical and diagnostic technologies.

Key Market Players

• Canon Medical Systems Corporation
• Carl Zeiss Meditec Inc.
• Revenio Group Corporation
• Eyenuk Inc.
• Essilor International SA
• HealPros LLC
• Millennium Surgical Corp.
• ONL Therapeutics
• Peek Vision Ltd
• Parata Systems LLC

Report Scope

In this report, the Global Retinal Detachment Diagnostic Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Retinal Detachment Diagnostic Market, By Disease Type

• Rhegmatogenous Retinal Detachment
• Exudative
• Serous or Secondary Retinal Detachment
• Tractional Retinal Detachment

Retinal Detachment Diagnostic Market, By Diagnostics

• Fundus Photography
• Ophthalmoscopy
• Digital Retinal Camera
• Fluorescent Retinal Angiography
• Others

Retinal Detachment Diagnostic Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Retinal Detachment Diagnostic Market.

Available Customizations:

Global Retinal Detachment Diagnostic Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Retinal Detachment Diagnostic Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Disease Type (Rhegmatogenous Retinal Detachment, Exudative, Serous or Secondary Retinal Detachment, Tractional Retinal Detachment)
  • 5.2.2. By Diagnostics (Fundus Photography, Ophthalmoscopy, Digital Retinal Camera, Fluorescent Retinal Angiography, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Retinal Detachment Diagnostic Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Disease Type
  • 6.2.2. By Diagnostics
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Retinal Detachment Diagnostic Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Disease Type
      • 6.3.1.2.2. By Diagnostics
  • 6.3.2. Canada Retinal Detachment Diagnostic Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Disease Type
      • 6.3.2.2.2. By Diagnostics
  • 6.3.3. Mexico Retinal Detachment Diagnostic Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Disease Type
      • 6.3.3.2.2. By Diagnostics

7. Europe Retinal Detachment Diagnostic Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Disease Type
  • 7.2.2. By Diagnostics
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Retinal Detachment Diagnostic Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Disease Type
      • 7.3.1.2.2. By Diagnostics
  • 7.3.2. France Retinal Detachment Diagnostic Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Disease Type
      • 7.3.2.2.2. By Diagnostics
  • 7.3.3. United Kingdom Retinal Detachment Diagnostic Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Disease Type
      • 7.3.3.2.2. By Diagnostics
  • 7.3.4. Italy Retinal Detachment Diagnostic Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Disease Type
      • 7.3.4.2.2. By Diagnostics
  • 7.3.5. Spain Retinal Detachment Diagnostic Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Disease Type
      • 7.3.5.2.2. By Diagnostics

8. Asia Pacific Retinal Detachment Diagnostic Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Disease Type
  • 8.2.2. By Diagnostics
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Retinal Detachment Diagnostic Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Disease Type
      • 8.3.1.2.2. By Diagnostics
  • 8.3.2. India Retinal Detachment Diagnostic Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Disease Type
      • 8.3.2.2.2. By Diagnostics
  • 8.3.3. Japan Retinal Detachment Diagnostic Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Disease Type
      • 8.3.3.2.2. By Diagnostics
  • 8.3.4. South Korea Retinal Detachment Diagnostic Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Disease Type
      • 8.3.4.2.2. By Diagnostics
  • 8.3.5. Australia Retinal Detachment Diagnostic Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Disease Type
      • 8.3.5.2.2. By Diagnostics

9. Middle East & Africa Retinal Detachment Diagnostic Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Disease Type
  • 9.2.2. By Diagnostics
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Retinal Detachment Diagnostic Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Disease Type
      • 9.3.1.2.2. By Diagnostics
  • 9.3.2. UAE Retinal Detachment Diagnostic Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Disease Type
      • 9.3.2.2.2. By Diagnostics
  • 9.3.3. South Africa Retinal Detachment Diagnostic Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Disease Type
      • 9.3.3.2.2. By Diagnostics

10. South America Retinal Detachment Diagnostic Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Disease Type
  • 10.2.2. By Diagnostics
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Retinal Detachment Diagnostic Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Disease Type
      • 10.3.1.2.2. By Diagnostics
  • 10.3.2. Colombia Retinal Detachment Diagnostic Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Disease Type
      • 10.3.2.2.2. By Diagnostics
  • 10.3.3. Argentina Retinal Detachment Diagnostic Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Disease Type
      • 10.3.3.2.2. By Diagnostics

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Retinal Detachment Diagnostic Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Canon Medical Systems Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Carl Zeiss Meditec Inc.
• 15.3. Revenio Group Corporation
• 15.4. Eyenuk Inc.
• 15.5. Essilor International SA
• 15.6. HealPros LLC
• 15.7. Millennium Surgical Corp.
• 15.8. ONL Therapeutics
• 15.9. Peek Vision Ltd
• 15.10. Parata Systems LLC

16. Strategic Recommendations

17. About Us & Disclaimer